Associated Papers
Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation.
El Tannouri R et al.
Familial Cancer, 2019
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
Hoyer J et al.
Bmc Cancer, 2018
Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients.
Spugnesi L et al.
Genes, Chromosomes & Cancer, 2016
Select a paper to view details